Lane & Associates’s Johnson & Johnson JNJ Stock Holding History

Lane & Associates’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$661K	Buy	3,985 +82	+2%	+$12.8K	0.36%	49
2024 Q4	$594K	Sell	3,903 -724	-16%	-$112K	0.31%	59
2024 Q3	$750K	Buy	4,627 +376	+9%	+$59.9K	0.41%	48
2024 Q2	$621K	Buy	4,251 +111	+3%	+$16.5K	0.37%	56
2024 Q1	$655K	Buy	4,140 +1,289	+45%	+$205K	0.41%	54
2023 Q4	$447K	Hold	2,851	–	–	0.33%	62
2023 Q3	$444K	Sell	2,851 -10	-0.3%	-$1.65K	0.36%	59
2023 Q2	$474K	Sell	2,861 -125	-4%	-$20.2K	0.38%	54
2023 Q1	$463K	Sell	2,986 -317	-10%	-$51.2K	0.41%	51
2022 Q4	$583K	Buy	+3,303	New	+$570K	0.55%	41

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lane & Associates's JNJ Position: Q1 2025 in Review

Lane & Associates increased its Johnson & Johnson (JNJ) stake by 2.1% in Q1 2025, buying an estimated $12.8K and bringing the position to 3,985 shares worth $661K. The position accounts for 0.36% of the portfolio, ranked #49.

Lane & Associates first reported a position in JNJ in Q4 2022 and has held it in 10 quarters since. The position peaked at $750K in Q3 2024. 4,148 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

Lane & Associates held 3,985 shares of Johnson & Johnson worth $661K as of Q1 2025.
Lane & Associates bought 82 Johnson & Johnson shares in Q1 2025, an estimated $12.8K.
Johnson & Johnson made up 0.36% of Lane & Associates's portfolio in Q1 2025, its #49 holding.
Lane & Associates first reported a position in Johnson & Johnson in Q4 2022 and has held it in 10 quarters since.
Lane & Associates's Johnson & Johnson position peaked at $750K in Q3 2024.
4,148 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Lane & Associates's 13F filing for Q1 2025, filed 1 May 2025.